1. Home
  2. KALV vs INDI Comparison

KALV vs INDI Comparison

Compare KALV & INDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo KalVista Pharmaceuticals Inc.

KALV

KalVista Pharmaceuticals Inc.

N/A

Current Price

$15.64

Market Cap

757.7M

Sector

Health Care

ML Signal

N/A

Logo indie Semiconductor Inc.

INDI

indie Semiconductor Inc.

N/A

Current Price

$3.60

Market Cap

784.1M

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
KALV
INDI
Founded
N/A
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Semiconductors
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
757.7M
784.1M
IPO Year
2014
2021

Fundamental Metrics

Financial Performance
Metric
KALV
INDI
Price
$15.64
$3.60
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
4
Target Price
$30.00
$6.25
AVG Volume (30 Days)
564.9K
3.1M
Earning Date
04-13-2026
05-20-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
6.17
EPS
N/A
N/A
Revenue
$50,000,000.00
$216,682,000.00
Revenue This Year
N/A
$32.19
Revenue Next Year
$108.37
$35.06
P/E Ratio
N/A
N/A
Revenue Growth
495.66
N/A
52 Week Low
$9.83
$1.53
52 Week High
$19.00
$6.05

Technical Indicators

Market Signals
Indicator
KALV
INDI
Relative Strength Index (RSI) 53.36 44.54
Support Level $14.45 $3.54
Resistance Level $16.33 $3.68
Average True Range (ATR) 0.69 0.26
MACD 0.07 -0.02
Stochastic Oscillator 80.05 44.38

Price Performance

Historical Comparison
KALV
INDI

About KALV KalVista Pharmaceuticals Inc.

KalVista Pharmaceuticals Inc is a pharmaceutical company developing and delivering oral therapies for individuals affected by rare diseases with unmet needs. The company applies its knowledge in the kallikrein-kinin system (KKS) and oral drug discovery to develop small-molecule protease inhibitor medicines to address the needs of patients with diseases driven by plasma kallikrein and Factor XIIa. Its FDA-approved product EKTERLY (sebetralstat) is a novel, orally delivered, small-molecule plasma kallikrein inhibitor for the treatment of acute attacks of hereditary angioedema (HAE) in adult and pediatric patients aged twelve years and older.

About INDI indie Semiconductor Inc.

Indie Semiconductor Inc is empowering the Autotech revolution with next-generation automotive semiconductors and software platforms. It focuses on edge sensors for Driver Assistance Systems including LiDAR, connected car, user experience, and electrification applications. These technologies represent the core underpinnings of both electric and autonomous vehicles, while the user interfaces transform the in-cabin experience to mirror and seamlessly connect to the mobile platforms. Geographically, the company generates majority of its revenue from Greater China and rest from United States, Europe, South Korea and other regions.

Share on Social Networks: